CervoMed Inc. · TRADEGATE:DP8

CervoMed Inc. financial statements

CervoMed Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue4.01M9.74M7.14M0000
Cost of revenue18.8M8.44M1.34M93.4K103.2K97.9K110.4K68.0K25.3K
Gross profit-9.06M-1.29M-1.34M-93.4K-103.2K-97.9K-110.0K-68.0K-25.3K
Research and development21.8M18.8M8.44M1.34M8.50M9.43M6.62M5.75M5.09M7.25M
Selling, general and administrative10.5M9.17M6.52M8.74M7.45M6.44M5.42M
Operating income-28.3M-18.2M-7.81M-3.48M-24.7M-16.0M-11.6M-19.0M-11.3M-18.4M
Depreciation and amortization1.94M5093.4K103.2K97.9K110.4K68.0K25.3K
EBITDA-16.3M-7.81M-3.48M-24.6M-15.9M-11.5M-18.8M-11.3M-18.3M
Interest expense05873.00K100.0K37.0K
Income before tax-27.0M-16.3M-2.17M-15.6M-24.5M-15.9M-11.5M-18.8M-2.42M-18.4M
Income tax0800.0K0-443.9K-1.68M332.9K-437.3K-1.06M-364.8K
Net income-27.0M-16.3M-2.17M-5.80M-24.1M-14.2M-11.8M-18.4M-1.36M-18.0M
Earnings per share, basic-2.98-2.02-0.82-11.20-12.38-0.30-1.76-8.21-3.16-1.76
Earnings per share, diluted2,038,891.001,946,859.0053,831,973.006,706,509.003,242,301.00-29.11-1.76

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents8.24M9.00M7.79M4.09M37.3M18.5M14.2M7.99M8.90M1.55M
Short-term investments12.6M29.9M012.4M0
Receivables427.0K2.25M915.4K69.6K
Current assets22.9M43.1M9.96M4.16M37.8M18.8M14.6M8.91M9.67M1.60M
Property, plant and equipment0149.2K252.4K350.3K460.7K79.8K
Goodwill06.93M6.93M
Total assets22.9M43.1M9.97M4.16M37.8M27.7M24.1M18.2M26.1M17.5M
Accounts payable1.45M1.51M662.5K97.3K947.5K545.8K1.25M198.8K512.0K1.68M
Current liabilities4.66M3.88M2.60M13.2M2.93M2.44M1.72M804.0K2.69M4.44M
Total debt12.4M10.0M149.2K247.0K550.0K2.43M
Total liabilities4.66M3.88M2.60M13.2M2.93M2.92M3.98M2.59M4.92M8.30M
Shareholders' equity18.2M39.2M7.38M-33.3M34.9M24.8M20.1M15.6M21.2M9.18M
Shares outstanding9.25M8.70M5.67M518.1K2.04M64.0M33.5M3.38M968.0K10.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-23.4M-16.5M-7.45M-2.57M-14.5M-13.6M-9.86M-10.8M-12.3M-10.8M
Capital spending0-3-3-10000-447.8K-2.33K
Free cash flow-23.4M-16.5M-7.45M-2.57M-14.5M-13.6M-9.86M-10.8M-12.8M-10.8M
Cash from investing18.1M-28.7M0-12.2M4.00K0-447.8K8.50M
Cash from financing4.59M46.4M11.1M033.3M17.9M16.0M9.87M20.1M1.83M
Change in cash-764.0K1.21M3.70M-2.57M18.8M4.34M6.19M-905.3K7.34M-444.3K